Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This is a study of the safety, tolerability, pharmacokinetics (measurement of drug levels in
the blood), and intraocular pressure lowering effects of OPA-6566 ophthalmic solution in
subjects with primary open-angle glaucoma or ocular hypertension.